RecruitingNot Applicable

Assessment of Clinically Related Outcomes and Biomarker Analysis for Translational Integration in Colorectal Cancer

Norway1,200 participantsStarted 2013-01-01

Plain-language summary

* A prospective, observational study on clinical outcomes of surgical management of primary and metastatic colorectal cancer * Prospective collection of tissues to explore potential biomarkers in blood and/or primary or secondary cancers and/or normal colon

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of colorectal cancer, primary or metastatic (liver), with a treatment intention of planned curative surgery * Informed consent to participate * Age ≥18 Exclusion Criteria: * failure to provide written informed consent

What they're measuring

Cancer-specific survival

Timeframe: 5-years

Trial details

NCT IDNCT01762813

SponsorHelse Stavanger HF

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2035-12-31

Contact for this trial

Ramesh L. Kajavi, RN

92297672 acro.gitan@gmail.com

View on ClinicalTrials.gov More Colorectal Cancer trials